Clinical trial
Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung…
NCT00030420 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00030420 |
|---|---|
| Title | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Evaluation Of Celecoxib In Combination With Docetaxel In The Treatment Of Advanced Non-Small Cell Lung Cancer Patients Previously Treated With Platinum Based Chemotherapy |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Celecoxib, Docetaxel |
| Enrollment | 24 |
| Start date | Oct 1, 2001 |
| Primary completion | May 1, 2004 |
| Completion | Feb 1, 2008 |
| First posted | Oct 21, 2003 |
| Last update posted | Apr 29, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: